CCM
TNDM icon

Coe Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Coe Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$406K Hold
4,164
– – 0.38% 73
2021
Q1 		$367K Buy
+4,164
New +$387K 0.37% 67

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Coe Capital Management's TNDM Position: Q2 2021 in Review

Coe Capital Management held its Tandem Diabetes Care (TNDM) position steady in Q2 2021 at 4,164 shares worth $406K. The position accounts for 0.38% of the portfolio, ranked #73.

Coe Capital Management first reported a position in TNDM in Q1 2021 and has held it in 2 quarters since. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2021.

  • Coe Capital Management held 4,164 shares of Tandem Diabetes Care worth $406K as of Q2 2021.
  • Coe Capital Management left its Tandem Diabetes Care share count unchanged in Q2 2021.
  • Tandem Diabetes Care made up 0.38% of Coe Capital Management's portfolio in Q2 2021, its #73 holding.
  • Coe Capital Management first reported a position in Tandem Diabetes Care in Q1 2021 and has held it in 2 quarters since.
  • 303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2021.

Based on Coe Capital Management's 13F filing for Q2 2021, filed 22 Jul 2021.